ENTRY       D06078                      Drug
NAME        Teriparatide (USP/INN);
            Teriparatide (genetical recombination) (JAN);
            Teriparatide (genetical recombination) [Teriparatide biosimilar 1] (JAN);
            Forteo (TN)
PRODUCT     FORTEO (Eli Lilly and Company)
            TERIPARATIDE (Alvogen)
FORMULA     C181H291N55O51S2
EXACT_MASS  4115.1309
MOL_WEIGHT  4117.7151
SEQUENCE    Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His Leu Asn
            Ser Met Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His
            Asn Phe-OH
  TYPE      Peptide
CLASS       Hormonal agent
             DG01661  Parathyroid hormone and analog
            Musculo-skeletal system agent
             DG03232  Osteoporosis agent
REMARK      Therapeutic category: 2439
            ATC code: H05AA02
            Chemical structure group: DG00512
            Product (DG00512): D06078<JP/US> D03358<JP>
EFFICACY    Antiresorptive, Osteoporosis agent, Parathyroid hormone receptor agonist
  DISEASE   Osteoporosis [DS:H01593]
COMMENT     Parathormone [CPD: C16051] analog
TARGET      PTH1R [HSA:5745] [KO:K04585]
  PATHWAY   hsa04080(5745)  Neuroactive ligand-receptor interaction
            hsa04928(5745)  Parathyroid hormone synthesis, secretion and action
            hsa04961(5745)  Endocrine and other factor-regulated calcium reabsorption
INTERACTION  
STR_MAP     map07047  Osteoporosis drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H05 CALCIUM HOMEOSTASIS
               H05A PARATHYROID HORMONES AND ANALOGUES
                H05AA Parathyroid hormones and analogues
                 H05AA02 Teriparatide
                  D06078  Teriparatide (USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Calcium Regulating Hormones
               Teriparatide
                D06078  Teriparatide (USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               243  Thyroid and parathyroid hormone preparations
                2439  Others
                 D06078  Teriparatide (USP/INN); Teriparatide (genetical recombination) (JAN); Teriparatide (genetical recombination) [Teriparatide biosimilar 1] (JAN)
            Drug groups [BR:br08330]
             Hormonal agent
              DG01661  Parathyroid hormone and analog
               DG00512  Teriparatide
                D06078  Teriparatide
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG00512  Teriparatide
                D06078  Teriparatide
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D06078  Teriparatide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Parathyroid hormone
                PTH1R
                 D06078  Teriparatide (USP/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D06078
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D06078
            Drug groups [BR:br08330]
             Hormonal agent
              DG01661  Parathyroid hormone and analog
               DG00512  Teriparatide
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG00512  Teriparatide
DBLINKS     CAS: 52232-67-4
            PubChem: 47207736
            NIKKAJI: J2.191.211E
///
